CHR — Chr Hansen Holding A/S Share News
0.000.00%
Last trade - 00:00- DKK73.91bn
- DKK80.85bn
- €1.33bn
Brief: Combination Of Novozymes, Chr. Hansen Is Completed
Brief: Novozymes Says All Necessary Regulatory Approvals Obtained For Combination Novozymes And Chr. Hansen
European Commission clears Novozymes, Chr. Hansen merger (updated)
European Commission clears Novozymes, Chr. Hansen merger
Novozymes, Chr. Hansen tie-up likely to win EU nod, sources say
Novozymes, Chr. Hansen tie-up likely to win EU nod, sources say
EU regulators likely to clear Novozymes, Chr. Hansen deal, sources say
Europe Research Roundup: Adevinta ASA, Anglo American, BMW
EU extends decision date on Novoyzmes, Chr. Hansen deal to Dec. 12
Exane BNP Paribas sees headwinds to reverse for ingredients cos
Brief: Novozymes: Remedy Proposal Related To Merger With Chr Hansen
Top of the Street: Smith+ Nephew, Chr Hansen, Accor
'Biosolutions Powerhouse' - Barclays upgrades Novozymes, Chr Hansen
Novozymes shares track best day in 11 months on 'nice beat' across the board
EU antitrust regulators set Nov. 28 deadline for Novozymes, Chr. Hansen deal
Europe Research Roundup: EasyJet, Kerry Group, Tate & Lyle
Brief: Chr. Hansen Holding Narrows Expectations To Organic Revenue Growth
Brief: Chr. Hansen Q4 Adjusted EBIT EUR 99 Million Vs. Estimate EUR 99 Million
Brief: Novozymes Announces Leadership Team, Organizational Structure For Combined Company